ACE1831

· Acepodia Biotech, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for ACE1831, covering 2025-08-11 to 2026-02-13. Get the full timeline:

Most recent: Clinical Trial Update: Study to Assess Safety, Efficacy and Persistence of ACE1831, in Subjects With IgG4-Related Disease [Phase 1, Phase 2]

See pricing